3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus

Neuroscience

Volumn 155, Issue 1, 2008, Pages 270-276

  Bonkale, W L ^a   Austin, M C ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT; 5 HT transporter; amphetamine; drug abuse; immunoautoradiography; in situ hybridization

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; IODINE 125; MESSENGER RNA; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BAY REGION BINDING SITE; CINGULATE GYRUS; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ENZYME REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; NERVE FIBER; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; RAT; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; STRATUM CORNEUM; TISSUE LEVEL; TISSUE SECTION;

ANIMALS; AUTORADIOGRAPHY; GENE EXPRESSION REGULATION; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PROTEIN BINDING; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE;

EID: 47249116917     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.03.086     Document Type: Article

References (45)

1. Abrams J.K., Johnson P.L., Hollis J.H., and Lowry C.A. Anatomic and functional topography of the dorsal raphe nucleus. Ann N Y Acad Sci 1018 (2004) 46-57
2. Ádori C., Andó R.D., Kovács G.G., and Bagdy G. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. J Comp Neurol 497 (2006) 251-269
3. Aguirre N., Galbete J.L., Lasheras B., and Del Rio J. Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats. Eur J Pharmacol 281 (1995) 101-105
4. Aguirre N., Frechilla D., Garcia-Osta A., Lasheras B., and Del Rio J. Differential regulation by methylenedioxymethamphetamine of 5-hydroxytryptamine1A receptor density and mRNA expression in rat hippocampus, frontal cortex, and brainstem: the role of corticosteroids. J Neurochem 68 (1997) 1099-1105
5. 1A receptor mRNA in neurons of the human brainstem. Synapse 18 (1994) 276-279
6. Austin M.C., and O'Donnell S.M. Regional distribution and cellular expression of tryptophan hydroxylase messenger RNA in postmortem human brainstem and pineal gland. J Neurochem 72 (1999) 2065-2073
7. Battaglia G., Yeh S.Y., O'Hearn E., Molliver M.E., Kuhar M.J., and de Souza E.B. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destro serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242 (1987) 911-916
8. Battaglia G., Sharkey J., Kuhar M.J., and de Souza E.B. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography. Synapse 8 (1991) 249-260
9. Bendotti C., Servadio A., Forloni G., Angeretti N., and Samanin R. Increased tryptophan hydroxylase mRNA in raphe serotonergic neurons spared by 5,7-dihydroxytryptamine. Mol Brain Res 8 (1990) 343-348
10. Bendotti C., Baldessari S., Ehret M., Tarizzo G., and Samanin R. Effect of d-fenfluramine and 5,7-dihydroxytryptamine on the levels of tryptophan hydroxylase and its mRNA in rat brain. Mol Brain Res 19 (1993) 257-261
11. Bonkale W.L., Murdock S., Janosky J., and Austin M.C. Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphe of depressed suicide victims. J Neurochem 88 (2004) 958-964
12. Chang M., Sved A.F., Zigmond M.J., and Austin M.C. Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience 101 (2000) 131-139
13. Clewans C.S., and Azmitia E. Tryptophan hydroxylase in hippocampus and midbrain following unilateral injection of 5,7-dihydroxytryptamine. Brain Res 307 (1984) 125-133
14. Cortès R., Mengod G., Celada P., and Artigas F. p-Chlorophenylalanine increases tryptophan-5- hydroxylase mRNA levels in the rat dorsal raphe: a time course study using in situ hybridization. J Neurochem 60 (1993) 761-764
15. Crawford C.A., Williams M.T., Kohutek J.L., Choi F.Y., Yoshida S.T., McDouglas S.A., and Vorhees C.V. Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats. Brain Res 1077 (2006) 178-186
16. Cumming P., Møller M., Benda K., Minuzzi L., Jakobsen S., Jensen S.B., Pakkenberg B., Stark A.K., Gramsbergen J.B., Andreasen M.F., and Olsen A.K. A PET study of effects of chronic 3,4-methylenedioxymethamphetamine (MDMA, "ectasy") on serotonin markers in Göttingen minipig brain. Synapse 61 (2007) 478-487
17. De Silva D.J., French S.J., Cheung N.Y., Swinson A.K., Bendotti C., and Rattray M. Rat brain serotonin neurons that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Neuroscience 134 (2005) 1363-1375
18. 2+/calmodulin dependent protein kinase. J Neurochem 52 (1989) 1886-1891
19. Fischer C., Hatzidimitriou G., Wlos J., Katz J., and Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurosci 15 (1995) 5476-5485
20. García-Osta A., Del Río J., and Frechilla D. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 4-methylenedioxymethamphetamine (MDMA, ecstasy) in the rat frontal and not in the hippocampus. Mol Brain Res 126 (2004) 181-187
21. Hatzidimitriou G., McCann U.D., and Ricaurte G.A. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-) 3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19 (1999) 5096-5107
22. Jequier E., Lovenberg W., and Lodish H.F. Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 3 (1967) 274-278
23. Johansen P.A., Jennings I., Cotton R.G.H., and Kuhn D.M. Tryptophan hydroxylase is phosphorylated by protein kinase A. J Neurochem 65 (1995) 882-888
24. Kerner J.A., Standaert D.G., Penney Jr. J.B., Young A.B., and Landwehrmeyer G.B. Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes. Brain Res Protoc 3 (1998) 22-32
25. Lew R., Sabol K.E., Chou C., Vosmer G.L., Richards J., and Seiden L.S. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. J Pharmacol Exp Ther 276 (1996) 855-865
26. Ljubic-Thibal V., Diksic M., and Hamel E. Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminal lesion. Synapse 32 (1999) 177-186
27. Martínez-Turrillas R., Moyano S., Del Río J., and Frechilla D. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus. Neurosci Lett 402 (2006) 126-130
28. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., and Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings. Lancet 352 (1998) 1433-1437
29. McGregor I.S., Van der Plasse G., Li K.M., Hunt G.E., Chen F., and Lawrence A.J. Increased anxiety 3 months after brief exposure to MDMA (ecstasy) in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 28 (2003) 1472-1484
30. McKinney J., Knappskog P.M., and Haavik J. Different properties of the central and peripheral forms of human tryptophan hydroxylase. J Neurochem 92 (2005) 311-320
31. Park D.H., Stone D.M., Baker H., Wessel T.C., Kim K.S., Towle A.C., and Joh T.H. Changes in activity and mRNA for rat tryptophan hydroxylase and aromatic L-amino acid decarboxylase of brain serotonergic cell bodies and terminals following neonatal 5,7-dihydroxytrypatamine. Brain Res 609 (1993) 59-66
32. Park D.H., Stone D.M., Baker H., Kim K.S., and Joh T.H. Early induction of rat brain tryptophan hydroxylase (TPH) mRNA following parachlorophenylalanine (PCPA) treatment. Mol Brain Res 22 (1994) 20-28
33. Patel P.D., Pontrello C., and Burke S. Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol Psychiatry 55 (2004) 428-433
34. Raison S., Rousset C., Pujol J.-F., and Weissmann D. p-Chlorophenylalanine-induced alteration of somatodendritic levels of tryptophan hydroxylase within the rat mesencephalic raphe nuclei. J Neurochem 67 (1996) 2124-2133
35. Salli U., Reddy A.P., Salli N., Lu N.Z., Kuo H.C., Pau F.K., Wolf D.P., and Bethea C.L. Serotonin neurons derived from rhesus monkey embryonic stem cells: similarities to CNS serotonin neurons. Exp Neurol 188 (2004) 351-364
36. Schmidt C.J., and Taylor V.L. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine. Biochem Pharmacol 36 (1987) 4095-4102
37. Semple-Rowland S.L., Mahatme A., and Rowland N.E. Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAs in rat dorsal raphe. Mol Brain Res 41 (1996) 121-127
38. Stachowiak M.K., Stricker E.M., Jacoby J.H., and Zigmond M.J. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochem Pharmacol 35 (1986) 1241-1248
39. 1A receptors and serotonin transporters in the human dorsal raphe. Brain Res 727 (1996) 1-12
40. Stone D.M., Stahl D.C., Hanson G.R., and Gibb J.W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128 (1986) 41-48
41. Stone D.M., Merchant K.M., Hanson G.R., and Gibb J.W. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26 (1987) 1677-1683
42. Walther D.J., Peter J.U., Bashamakh S., Hortnagl H., Voits M., Fink H., and Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299 (2003) 76
43. Widelitz M.M., Coryell M.R., Widelitz H., and Avadhani M.G. Dissociation of rat brain polyribosomes in vivo by amphetamines. Brain Res 100 (1975) 215-220
44. Xie T., Tong L., Mclane M.W., Hatzidimitriou G., Yuan J., McCann U., and Ricaurte G. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 31 (2006) 2639-2651
45. Zill P., Büttner A., Eisenmenger W., Möller H.-J., Ackenheil M., and Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: A post-mortem study. J Psychiatr Res 41 (2007) 168-173